Explore the Agenda
8:00 am Check In, Coffee & Light Breakfast
Workshop Track 1
Technical Track for Site-Level EHS Professionals
9:00 am Workshop A: Practical Biosafety Risk Management for the Handling of Emerging Modalities
Dive into the day-to-day realities of managing biosafety in evolving biopharma environments. Participants will tackle the practical side of working with live agents, hybrid hazards, and novel compounds, where toxicology data is scarce, contractors vary in competence, and operational demands can compromise safety. Take-away strategies for maintaining robust biosafety without slowing innovation.
Key Questions to Be Addressed
- How can site teams justify and protect biosafety controls, such as BSCs or isolators, when operational or space constraints challenge their necessity?
- What workable approaches exist for safely handling novel compounds and live materials when toxicological or exposure data are incomplete?
- How can teams verify validation quality, leak testing, and equipment integrity when local regulations or contractor experience are limited?
- What training methods, peer learning, or digital tools can quickly upskill teams transitioning to advanced modalities like ADCs, radiopharma, or gene therapy?
- How can site-level leaders foster a biosafety culture where biological risks are recognised early, discussed openly, and prioritised alongside productivity?
Workshop Track 2
Strategic Track for Global EHS Leaders
9:00 am Workshop B: Leading Global EHS Through Organisational Change & Regulatory Flux
In today’s volatile biopharma landscape, effective EHS leadership demands adaptability, foresight, and influence. This interactive workshop equips global leaders to navigate shifting regulations, tightening
budgets, and organisational flux while sustaining a strong safety culture. Through peer exchange and scenario-led discussion, participants will learn how to lead with flexibility, maintain global alignment, and position EHS as a driver of trust, continuity, and performance.
Key Questions to Be Addressed
- How can senior leaders anticipate regulatory shifts and build foresight into strategy before compliance pressures force reactive change?
- What leadership behaviours and governance models enable standardisation with local autonomy across diverse regions and risk profiles?
- How can EHS priorities remain visible and adequately funded when capital is scarce, and business pressures dominate executive decision-making?
- What communication strategies help reposition EHS from a compliance function to a value-creating partner in business resilience and innovation?
- How can leaders foster psychological safety and engagement, so teams stay motivated, accountable, and adaptive during constant change?
12:00 pm Lunch & Networking Break
1:00 pm Workshop C: Waste, Wastewater, & Responsibility: Managing Novel & Biological Materials in a Complex Regulatory Landscape
Explore one of biopharma’s most pressing EHS challenges: managing hazardous, biological, and wastewater streams responsibly across emerging modalities. From ADCs and gene therapies to PFAS and radiopharmaceuticals, participants will examine real-world regulatory gaps, vendor partnerships, and accountability issues that extend beyond the lab. Delegates will walk away with strategies for aligning government oversight, contractor competence, and internal sustainability goals to create a resilient, transparent waste management culture.
Key Questions to Be Addressed:
- How can sites maintain oversight once hazardous or biological waste leaves the facility, especially in regions with weak regulations or limited contractor competence?
- How should hybrid compounds like ADCs be classified and disposed of responsibly to balance chemical and biological risks?
- What systems or partnerships can improve coordination and traceability across regulators, vendors, and contractors?
- How can sites manage biologics- or PFAS-contaminated wastewater to meet discharge limits and prevent downstream contamination?
- How can data sharing and AI tools optimise costly waste and incineration decisions while ensuring compliance and sustainability?
1:00 pm Workshop D: Beyond Compliance: Building Sustainable Safety Cultures Across All Sites from Top-Down Leadership
This interactive session explores how biopharma organisations can evolve beyond compliance-driven EHS systems to embed sustainable, human-centred safety cultures across global operations. Through real-world examples and group discussion, delegates will examine the interplay between compliance, behaviour, and cultural context. Participants will walk away with actionable insights on engaging leadership, strengthening psychological safety, and integrating softer
skillsets and wellbeing practices into rigorous EHS frameworks to ensure that safety is lived, not just logged.
Key Questions to Be Addressed
- How can biopharma organisations shift from compliance to a culture integrating human performance, soft skills, and behavioural insight?
- How can EHS leaders adapt global safety culture to local norms while maintaining consistent standards?
- How can management become active champions of EHS, fostering both top-down and bottom-up engagement?
- What role do wellbeing, stress management, and open dialogue play in sustaining trust and participation?
- How can we challenge legacy mindsets to nurture curiosity, psychological safety, and innovation in EHS culture?